Jason Lamar Vittitow

Title: Jason Lamar Vittitow: Innovator in Glaucoma Treatment

Introduction

Jason Lamar Vittitow is a notable inventor based in Flanders, NJ (US). He has made significant contributions to the field of ophthalmology, particularly in the treatment of normal tension glaucoma. His innovative approach has the potential to improve the quality of life for many patients suffering from this condition.

Latest Patents

Vittitow holds a patent for "Nitric oxide releasing prostaglandin derivatives for treating normal tension glaucoma." This invention provides a method of lowering intraocular pressure in a patient with normal tension glaucoma. The method involves contacting the eye of a subject with a pharmaceutical composition that includes an effective amount of Nitric Oxide releasing prostaglandin derivatives of a specific formula. This advancement represents a promising avenue for glaucoma treatment.

Career Highlights

Throughout his career, Jason Lamar Vittitow has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Nicox S.A. and Bausch + Lomb Incorporated. His experience in these organizations has contributed to his expertise in developing innovative solutions for eye care.

Collaborations

Vittitow has collaborated with various professionals in his field, including his coworker Megan Elizabeth Cavet. These partnerships have fostered an environment of innovation and have led to advancements in glaucoma treatment.

Conclusion

Jason Lamar Vittitow is a distinguished inventor whose work in glaucoma treatment showcases his commitment to improving patient outcomes. His patent for nitric oxide releasing prostaglandin derivatives represents a significant step forward in ophthalmic therapies.